JOURNAL OF MOLECULAR MODELING, published by Springer, is a pivotal resource for researchers and professionals in the fields of chemistry, computer science, and molecular sciences. The journal's ISSN is 1610-2940, with an E-ISSN of 0948-5023, reflecting its commitment to disseminating cutting-edge research from 1996 to 2024. Although the journal does not operate under an Open Access model, it remains an invaluable platform for the publication of innovative studies related to computational methods, theoretical chemistry, and molecular simulations. With a notable categorization across multiple quartiles—including Q4 in Catalysis and Q3 in Computational Theory and Mathematics—the journal holds a distinct rank in Scopus, highlighting its influence and contribution to the discipline. The importance of this journal lies in its ability to bridge the gap between theoretical understanding and practical applications, making it essential reading for students and scholars seeking to advance their knowledge and research in molecular modeling.

SynOpen is an esteemed open-access journal published by GEORG THIEME VERLAG KG, based in Germany, dedicated to advancing the fields of Biomaterials, Catalysis, Materials Science, and Organic Chemistry. Since its inception in 2017, the journal has established itself as a vital platform for researchers wishing to disseminate their findings in a rapidly evolving scientific landscape, earning a commendable Q2 ranking in Materials Science (miscellaneous) and Q3 in other key categories for 2023. With an increasing impact on its disciplines, SynOpen aims to foster interdisciplinary collaboration and innovation by providing unrestricted access to high-quality research, thus promoting a broader reach and visibility for authors. Scholars, professionals, and students alike can benefit from the comprehensive range of topics covered, as the journal's commitment to presenting cutting-edge studies and methodologies positions it as a crucial resource for contemporary scientific inquiry.

BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, published by the esteemed Chemical Society of Japan, serves as a pivotal platform for the dissemination of cutting-edge research in the multifaceted field of chemistry. With an ISSN of 0009-2673 and an E-ISSN of 1348-0634, this journal has been integral in fostering the growth of chemical sciences globally since its inception in 1965. The journal holds an impressive Q2 ranking in the Chemistry (miscellaneous) category, indicating its relevance and influence within the academic community, as reflected by its Scopus rank of #104/408, placing it in the 74th percentile. Although it is not an open-access journal, its rich content, which spans a wide range of topics in general chemistry, remains highly valued by researchers, professionals, and students alike, affirming its crucial role in advancing both theoretical knowledge and practical applications in chemistry. As it converges towards 2024, the bulletin continues to uphold its commitment to excellence in scientific communication and research dissemination in Japan and beyond.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

The Journal of Saudi Chemical Society, published by ELSEVIER, stands as a premier platform for advancing knowledge in the field of chemistry. Since its inception in 2009, this Open Access journal has garnered significant attention, securing a prestigious Q1 ranking in the Chemistry (miscellaneous) category for 2023, reflecting its position among the top journals in the discipline. With an impressive Scopus ranking of #66 out of 408 in General Chemistry, this journal boasts a commendable 83rd percentile, underscoring its impact and relevance in the global research community. The journal aims to disseminate high-quality research articles, reviews, and case studies, fostering innovation and collaboration among chemists and allied professionals. By enabling widespread access to cutting-edge research, the Journal of Saudi Chemical Society plays a crucial role in supporting the educational and professional development of students, researchers, and practitioners alike, making it an essential resource for anyone invested in the dynamic field of chemistry.

The Jordan Journal of Chemistry is a prominent publication dedicated to advancing the field of chemistry in Jordan and beyond. Published by the Yarmouk University Deanship of Research & Graduate Studies, this journal serves as a platform for researchers, educators, and practitioners to disseminate their findings in a variety of chemistry sub-disciplines. Although currently classified in Q4 of miscellaneous chemistry and ranking within the 9th percentile according to Scopus, the journal plays a crucial role in fostering academic dialogue and collaboration in the region. With its ISSN 1814-9111 and E-ISSN 2079-7249, the Jordan Journal of Chemistry offers open access to researchers from diverse backgrounds, ensuring that critical research is both accessible and impactful. By bridging local studies with global scientific advancements, this journal is poised to contribute significantly to the growth and recognition of chemistry as a key scientific discipline in the region, with convergence efforts set from 2020 to 2024.

Frontiers in Chemistry is an esteemed and innovative Open Access journal published by FRONTIERS MEDIA SA, based in Lausanne, Switzerland. Since its inception in 2013, the journal has established itself as a leading platform for the dissemination of high-quality research across a broad spectrum of chemistry disciplines, achieving a notable Q1 classification in the miscellaneous chemistry category as of 2023. With an impressive Scopus rank, placing it at 72nd out of 408 in General Chemistry and falling within the 82nd percentile, Frontiers in Chemistry is committed to publishing significant findings that contribute to the advancement of the field. The journal's Open Access model ensures that research is freely accessible to all, fostering a greater exchange of knowledge and collaboration among researchers, professionals, and students globally. It covers a range of topics, from organic and inorganic chemistry to materials science and biochemistry, making it an essential resource for anyone seeking to stay at the forefront of chemical research.

Heterocyclic Letters is an esteemed journal in the field of synthetic organic chemistry, published by RAMAN PUBL. With ISSN 2231-3087 and E-ISSN 2230-9632, this journal aims to disseminate original research and innovative findings related to heterocyclic compounds, which play a crucial role in medicinal chemistry, material science, and agricultural chemistry. Heterocyclic Letters provides a platform for researchers, professionals, and students to share their insights and advancements, thus fostering academic collaboration and knowledge transfer. The journal is dedicated to maintaining high-quality standards in research publication, making it an essential resource for anyone focused on the latest developments in heterocyclic chemistry. Although it does not currently offer Open Access options, the journal’s rigorous peer-review process ensures that only the most credible and impactful studies are published, contributing significantly to the advancement of the field.